Clinical Trial Update: Clinical Trial of Systolic Heart Failure Treatment of IvabRadine Hemisulfate Sustained-release Tablets （FIRST） [Phase 2, Phase 3]

View source ↗

Summary

This is a clinical trial update for IvabRadine Hemisulfate Sustained-release Tablets in chronic systolic heart failure, spanning Phase 2 and Phase 3. Sponsor: J…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systolic Heart Failure

Drugs mentioned

• IvabRadine Hemisulfate Sustained-release Tablets (ivabradine hemisulfate sustained-release)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Chronic Systolic Heart Failure | Phase 2, Phase 3 | Status: UNKNOWN